The persistence of p190 BCR-ABL transcripts is associated with lower probability of molecular response to imatinib in early and late chronic phase CML patients.

被引：0
|
作者：
Garuti, A
Ibatici, A
Cirmena, G
Miglino, M
Varaldo, R
Nicoletta, C
Grasso, R
Pozzi, S
Podesta, M
Gobbi, M
Sessarego, M
Patrone, F
Frassoni, F
机构：
[1] Osped San Martino Genova, Dept HematoOncol, Ctr Cellule Staminali & Terapia Cellulare, Genoa, Italy
[2] Osped San Martino Genova, Dipartimento Med Interna, Genoa, Italy
[3] Osped San Martino Genova, Clin Ematol, Genoa, Italy
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
10.1182/blood.V106.11.3282.3282
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3282
引用
收藏
页码：917A / 918A
页数：2
相关论文
共 50 条
  • [31] BCR-ABL tumor burden and mutation status are independent predictive markers for molecular response in chronic phase CML patients treated with dasatinib after imatinib failure
    Hanfstein, B.
    Erben, P.
    Ernst, T.
    Schenk, T.
    Agrawal, M.
    Hofmann, W-K
    Hochhaus, A.
    Mueller, M. C.
    ONKOLOGIE, 2010, 33 : 145 - 145
  • [32] PRETREATMENT BCR-ABL TUMOR BURDEN AND MUTATION STATUS ARE INDEPENDENTLY PREDICTIVE FOR MOLECULAR RESPONSE IN CHRONIC PHASE CML PATIENTS TREATED WITH DASATINIB AFTER IMATINIB FAILURE
    Hanfstein, B.
    Erben, P.
    Ernst, T.
    Schenk, T.
    Agrawal, M.
    Hofmann, W. K.
    Hochhaus, A.
    Mueller, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 59 - 59
  • [33] The kinetics of BCR-ABL transcript levels in CML patients in chronic or accelerated phase during imatinib mesylate treatment.
    Klamova, H
    Moravcova, J
    Zmekova, V
    Voglova, J
    Faber, E
    BLOOD, 2003, 102 (11) : 325B - 326B
  • [34] Coexistence of p190 and "Aberrant" BCR-ABL1 fusion transcripts in p210+ chronic myelogenous leukemia (CML) are transient and correlate with complex karyoytpe
    Jiang, X. Y.
    Zhao, P.
    Wellings, M.
    Low, S.
    Engel, M.
    Shavghnessy, Z.
    Howell, J. M.
    Roland, B.
    Sinclair, G. D.
    Mansoor, A.
    LABORATORY INVESTIGATION, 2007, 87 : 247A - 247A
  • [35] In patients with chronic myelogeneous leukemia (CML), response dynamics to nilotinibafter imatinib failure depend on thetype of BCR-ABL mutations
    Soverini, S.
    Saglio, G.
    Branford, S.
    Radich, J.
    Kim, D. W.
    Hughes, T.
    Mueller, M.
    Erben, P.
    Hochhaus, A.
    Shou, Y.
    Weitzman, A.
    Baccarani, M.
    Martinelli, G.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 320 - 320
  • [36] BCR/ABL p210, p190 and p230 fusion genes in 250 Mexican patients with chronic myeloid leukaemia (CML)
    Arana-Trejo, RM
    Sánchez, ER
    Ignacio-Ibarra, G
    de la Fuente, EB
    Garces, O
    Morales, EG
    Granados, MC
    Martínez, RO
    Rubio-Borja, ME
    Anaya, LS
    Herrera, P
    Llamas, JD
    Kofman, S
    CLINICAL AND LABORATORY HAEMATOLOGY, 2002, 24 (03): : 145 - 150
  • [37] Prediction for Sustained Deep Molecular Response of BCR-ABL Levels in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP)
    Sasaki, Koji
    Kantarjian, Hagop M.
    O'Brien, Susan
    Ravandi, Farhad
    Konopleva, Marina
    Borthakur, Gautam
    Garcia-Manero, Guillermo
    Wierda, William G.
    Daver, Naval
    Ferrajoli, Alessandra
    Takahashi, Koichi
    Jain, Preetesh
    Rios, Mary Beth
    Pierce, Sherry
    Jabbour, Elias J.
    Cortes, Jorge E.
    BLOOD, 2016, 128 (22)
  • [38] Coexistence of p190 and "Aberrant" BCR-ABL1 fusion transcripts in p210+ chronic myelogenous leukemia (CML) are transient and correlate with complex karyoytpe
    Jiang, X. Y.
    Zhao, P.
    Wellings, M.
    Low, S.
    Engel, M.
    Shavghnessy, Z.
    Howell, J. M.
    Roland, B.
    Sinclair, G. D.
    Mansooc, A.
    MODERN PATHOLOGY, 2007, 20 : 247A - 247A
  • [39] High BCR-ABL/GUSIS Levels at Diagnosis of Chronic Phase CML Are Associated with Unfavorable Responses to Standard-Dose Imatinib
    Vigneri, Paolo
    Stagno, Fabio
    Stella, Stefania
    Cupri, Alessandra
    Forte, Stefano
    Massimino, Michele
    Antolino, Agostino
    Siragusa, Sergio
    Mannina, Donato
    Impera, Stefana Stella
    Musolino, Caterina
    Malato, Alessandra
    Mineo, Giuseppe
    Tomaselli, Carmela
    Murgano, Pamela
    Musso, Maurizio
    Morabito, Fortunato
    Molica, Stefano
    Martino, Bruno
    Manzella, Livia
    Mueller, Martin C.
    Hochhaus, Andreas
    Di Raimondo, Francesco
    CLINICAL CANCER RESEARCH, 2017, 23 (23) : 7189 - 7198
  • [40] Detection of p190BCR-ABL AND p210BCR-ABL fusion transcripts in patients with chronic myeloid leukemia (CML) using qualitative RT-PCR
    Aya Bonilla, Carlos Alberto
    Domingo Torres, Jose
    Enrique Muskus, Carlos
    Ramirez Gaviria, Gloria
    Cuervo Sierra, Jorge
    Sierra Sanchez, Margarita
    Cuellar-Ambrosi, Francisco
    Botero Garces, Jorge Humberto
    Artigas A., Carmen Gloria
    Mario Muneton, Carlos
    Vasquez Palacio, Gonzalo
    IATREIA, 2014, 27 (04) : 398 - 409
12345